CAMPBELL SHANNON received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/27/2026ACC: 0002018966-26-000005
Director
Since May 2026
+114.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
114.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+114.20K
Price / share
—
Trade value
—
% of position
New position
5/26/2026
0.00→114.20K
Total
Net shares
+114.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | A · Award | +114.20K | — | — | New position | 0.00 | 114.20K |
| Total | +114.20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported